DEREK MCCLURE: Open Payments
NPI 1184738338 · WEST JEFFERSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 18 payments from 10 companies in 2025. Trend: 2023 $2,069 · 2024 $9,364 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| Amgen Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $9 |
Products named: CAPLYTA, Wegovy, UBRELVY, REXULTI, OTEZLA, REPATHA, LEQVIO, FARXIGA.
Industry payments across NC — which companies pay providers there.
